Stock BIOC GLAXOSMITHKLINE S.A.E
Add to a list
To use this feature you must be a member
Log inSign up

All News GlaxoSmithKline S.A.E

Equities

BIOC

EGS38171C012

End-of-day quote Egyptian Exchange
Other stock markets
 18:00:00 2024-05-18 EDT 		5-day change 1st Jan Change
29 EGP +2.44% Intraday chart for GlaxoSmithKline S.A.E +0.76% -18.42%
03-04 GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023
CI
GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
GlaxoSmithKline S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
GlaxoSmithKline S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2021
CI
GlaxoSmithKline E : Glaxo Smith Kline (BIOC.CA) - Listing Committee Decision
PU
GSK hires former Tesco boss Sir Dave Lewis to head up £40bn spin-off
AQ
GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
GlaxoSmithKline S.A.E Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021
CI
Glaxosmithkline S.A.E Reports Standalone and Consolidated Financial Results for the Quarter Ended March 31, 2021
CI
Glaxosmithkline S.A.E Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2020
CI
Hikma Pharmaceuticals PLC cancelled the acquisition of GlaxoSmithKline S.A.E.
CI
Glaxo Group Receives Letter from ACDIMA for Acquisition of Glaxosmithkline Shares
CI
Hikma Pharmaceuticals PLC entered into a non-binding term sheet to acquire 91.2% stake in GlaxoSmithKline S.A.E from Glaxo Group Limited.
CI
GlaxoSmithKline S.A.E Reports Audited Standalone Earnings Results for the Year Ended December 31, 2019
CI
GSK Egypt to Launch 2 Production Lines with EGP 100 million Investments
CI
Glaxo Smith Kline Announces Consolidated Earning Results for the Nine Months Ended September 30, 2018
CI
GlaxoSmithKline S.A.E Announces Consolidated and Standalone Earnings Results for the First Quarter Ended March 31, 2018
CI
GlaxoSmithKline S.A.E Announces Consolidated and Standalone Earnings Results for the Six Months Ended June 30, 2018
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOC Stock
  4. News GlaxoSmithKline S.A.E
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW